# Organ Protective Effect of Cetirizine In Patients With Severe Burns

> **NCT06126991** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Ruijin Hospital** · enrollment: 32 (estimated)

## Conditions studied

- Burns

## Interventions

- **DRUG:** Cetirizine
- **DRUG:** Midazolam and Fentanyl

## Key facts

- **NCT ID:** NCT06126991
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-23
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2024-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06126991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06126991, "Organ Protective Effect of Cetirizine In Patients With Severe Burns". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06126991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*